Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Triamcinolone Acetonide × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Dermatologic 1 Breast 1

Conditions

Lung Neoplasms 1 Exanthema 1

Interventions

Carboplatin 329 Pemetrexed 271 Cisplatin 226 Paclitaxel 192 pembrolizumab 172 Erlotinib Hydrochloride 172 Docetaxel 151 Gemcitabine 125 Nivolumab 110 Bevacizumab 110 Radiotherapy 82 Etoposide 68 durvalumab 59 atezolizumab 55 Ipilimumab 50 Radiosurgery 47 osimertinib 41 130-nm albumin-bound paclitaxel 40 Afatinib 39 Gefitinib 38 Cetuximab 37 Albumin-Bound Paclitaxel 36 Taxes 32 Vinorelbine 29 Topotecan 27 Radiation 25 Drug Therapy 24 Crizotinib 23 Platinum 21 Dexamethasone 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡